WO1993011224A1 - Culture media for cells of marine invertebrates - Google Patents
Culture media for cells of marine invertebrates Download PDFInfo
- Publication number
- WO1993011224A1 WO1993011224A1 PCT/FR1992/001147 FR9201147W WO9311224A1 WO 1993011224 A1 WO1993011224 A1 WO 1993011224A1 FR 9201147 W FR9201147 W FR 9201147W WO 9311224 A1 WO9311224 A1 WO 9311224A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cells
- supplement
- culture
- growth factor
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0601—Invertebrate cells or tissues, e.g. insect cells; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/02—Atmosphere, e.g. low oxygen conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/02—Compounds of the arachidonic acid pathway, e.g. prostaglandins, leukotrienes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
Definitions
- the invention relates to new cell culture media suitable for cell culture of marine invertebrates, in particular for cell culture of molluscs.
- Invertebrate cell cultures first appeared in the 1930s. They were mainly oriented towards insect cell cultures, due to their numerous applications in virology and pathology. These cultures have since grown rapidly and are now used on an industrial scale for the production of recombinant proteins (baculovirus system). It is not the same for other inver ⁇ tebrates, and particularly for molluscs; attempts to culture mollusc cells have been quite numerous, but punctual and little followed; few species have been cultured, and the work undertaken has not resulted in the development of a culture medium allowing significant cell proliferation in vitro.
- the first culture media for marine mollusc cells consisted of filtered, buffered seawater, supplemented with antibiotics, carbohydrates and nitrogen in the form of amino acids or protein extract [VAGO and CHASTANG , CR Acad. Sci. , 250, 2751-2753 (i960)].
- the composition of the hemolymph (the extracellular fluid bathing the cells of invertebrates) was acquired, and the composition of the culture media was modeled on the composition of the hemolymph: the culture medium is the reconstitution as faithful as possible to the organic and mineral composition and the physicochemical characteristics of the hemolymph of the animal placed in culture [CHERNIN, J. Parasitol., 49, 353-364 (1963)].
- composition of the hemolymph varies between different groups of invertebrates, and within the same genus, between species. This composition also has great intraspecific variability: the composition of the oyster hemolymph varies, for example, depending on the season and the habitat.
- - a constant part comprising an organic fraction (carbohydrates, lipids and amino acids), antibiotics, and serums providing vitamins and non-specific growth factors.
- a part which varies according to the species cultivated comprising a mineral fraction (mineral salts in specific proportions, making it possible to adjust the osmotic pressure to the desired value), a special fraction (specific vitamins and growth factors) , and a fraction allowing the pH to be buffered to the desired value.
- a mineral fraction mineral salts in specific proportions, making it possible to adjust the osmotic pressure to the desired value
- a special fraction specific vitamins and growth factors
- the cells are generally cultivated between 15 "and 25 * C, at a pH varying between 6.8-7.0 and 7.2-7.4 and at the same osmotic pressure as that of the hemolymph, ie between 900 and 1100 mosmol / 1.
- the culture supplements used are very varied: so-called "indefinite” supplements, the chemical composition of which is not specified, such as the homologous or heterologous hemolymph inactivated, at 5 or 10%, fetal calf serum at 10%, bovine serum, horse serum, extracts of organs or whole animals, embryonic chicken extracts, or so-called “defined” supplements such as: protein hydrolysates, amino acids, vitamins, factors specific or non-specific growth, etc.
- indefinite supplements the chemical composition of which is not specified, such as the homologous or heterologous hemolymph inactivated, at 5 or 10%, fetal calf serum at 10%, bovine serum, horse serum, extracts of organs or whole animals, embryonic chicken extracts, or so-called “defined” supplements such as: protein hydrolysates, amino acids, vitamins, factors specific or non-specific growth, etc.
- Marine invertebrates and more particularly bivalve molluscs do not have an interior environment proper, and are not capable of homeostasis. They have specific enzyme systems, adapted to lower temperatures (15- 20 ° C) and at higher pressures; the substrates do not have the same affinities for these enzymes as for vertebrate enzymes. (Km, etc ).
- the cultures are carried out in hyperosmotic environments: (1100 mosmol / 1, or 3 to 4 times more than the conventional osmolarity of the environments for vertebrates which is about 300 mosmol / 1).
- the salinity of the media is brought to about 35 g / l of dissolved salts.
- hypersaline conditions the permeability of the membranes is impaired, and the exchange capacities between the cells and their environment reduced.
- PCT Application US 88/03325 describes, for example, a culture process allowing cells of explants from oyster coats intended for pearl production to be kept alive, in a medium comprising a saline solution simulating the natural medium associated with the tissue oyster coat; amino acids, assimilable sugars, and a supplement such as hemolymph, mollusc gonad extracts, yeast extract or fetal calf serum.
- a culture process allowing cells of explants from oyster coats intended for pearl production to be kept alive, in a medium comprising a saline solution simulating the natural medium associated with the tissue oyster coat; amino acids, assimilable sugars, and a supplement such as hemolymph, mollusc gonad extracts, yeast extract or fetal calf serum.
- the use of such media allows maintenance in primary cultures of adult cells, therefore differentiated, of molluscs, for periods ranging from a few days to several months.
- the present invention which was produced by the Applicant in collaboration with the Laboratory of Marine Invertebrate Biology of the Museum of Natural History, has set itself the goal of providing culture media which respond better than the media of ancient art. ⁇ laughing at the needs of marine invertebrate cells, in particular molluscs, and allowing the culture of adult cells, ensuring longer survival, and better proliferation of these cells in culture and in particular in secondary cultures.
- a culture medium which comprises, in addition to a basic mineral and organic medium, a new supplement, hereinafter called “defined supplement”, and possibly, a so-called “indefinite” supplement (c (i.e. a serum or hemolymph supplement, the exact chemical composition of which cannot be determined with precision).
- defined supplement a new supplement
- indefinite supplement i.e. a serum or hemolymph supplement, the exact chemical composition of which cannot be determined with precision.
- the constituents of the defined supplement according to the invention have already been described, among others, as active on the growth of cells in culture, in the case of cells of mammals and other vertebrates. However, the association of these constituents had never been proposed before, nor had it been suggested that they could have a favorable effect on the viability of the cultures of cells of marine invertebrates, and in particular of molluscs.
- the subject of the present invention is a composition which can be used as a defined supplement for a cell culture medium intended for the culture of marine invertebrates, which composition is characterized in that it comprises, at least one hormone chosen from the group comprising insulin, IGF (Insulin like Growth Factor), hydrocortisone and glycocorticoids, at least one growth factor chosen from the group comprising EGF (Epidermal Growth Factor), FGF (Fibroblast Growth Factor), and PDGF (Platelet Derived Growth Factor), at least one lipid substance or extract chosen from the group comprising Ex-Cyte VLE, egg yolk extract, and prostaglandin F2 ⁇ , and at least one protective agent chosen from free radical inhibitors.
- IGF Insulin like Growth Factor
- hydrocortisone and glycocorticoids at least one growth factor chosen from the group comprising EGF (Epidermal Growth Factor), FGF (Fibroblast Growth Factor), and PDGF (Platelet Derived Growth Factor)
- EGF Epidermal
- the supplement defined for cell cultures in accordance with the invention comprises between 10 and 100 ⁇ g / ml of bovine insulin, between 10 ⁇ ⁇ and 10 ⁇ 4 M hydrocortisone, between 5 and 50 ng / ml of EGF, between 1 and 25 ng / ml of PDGF, between 0.2 and 2% (v / v) of egg yolk extract, between 0.05 and 0.2% v / v of Ex-cyte VLE, between 10 ⁇ 9 and 2 x 10 ⁇ 8 M prostaglandin F2 ⁇ , between 10 and 100 ⁇ g / ml of catalase.
- the inventor further noted that the effect of the supplement defined in accordance with the invention was considerably increased when the said supplement was combined with a supplement of the "indefinite" type such as fetal calf serum or hemolymph. oyster.
- the invention also encompasses cell culture media suitable for the culture of marine invertebrate cells, in particular molluscs, which media are characterized in that they comprise a basic medium comprising mineral salts, sugars, acids amino, and vitamins, to which is added a defined supplement for cell cultures in accordance with the invention.
- cell culture media in accordance with the invention, they also comprise an indefinite supplement chosen from the group consisting of fetal calf serum or oyster hemolymph.
- the media in accordance with the invention consist for example of a commercial mineral and organic base (RPMI 1640, LEIBOVITZ L-15, etc.) to which mineral salts are added (NaCl, KC1, CaCl2, MgCl 2 , MgS ⁇ 4), antibiotics (penicillin, streptomycin) and supplements of indefinite composition (fetal calf serum, hemolymph, ...) and a supplement of defined composition in accordance with the invention.
- mineral salts NaCl, KC1, CaCl2, MgCl 2 , MgS ⁇ 4
- antibiotics penicillin, streptomycin
- supplements of indefinite composition fetal calf serum, hemolymph, ...) and a supplement of defined composition in accordance with the invention.
- the present invention further relates to a method of culturing marine invertebrate cells, characterized in that said cells are cultured in a medium comprising the defined supplement according to the invention.
- the inventor also found that the development and survival of cultures of marine invertebrate cells are further improved when the use of culture media comprising the defined supplement in accordance with the invention is combined with the culture of cells in an atmosphere. poor in oxygen.
- said cells are cultured under an atmosphere containing less than 10% oxygen.
- the cells are cultured under an atmosphere containing less than 5% oxygen.
- the defined supplement in accordance with the present invention has the following advantages over supplements of the prior art: it improves the short-term viability and the long-term survival of cultures of marine invertebrate cells; it can replace fetal calf serum in these cultures, and acts in synergy with it to improve cell viability and survival; its effect is increased by the reduction of the partial oxygen pressure.
- the present invention will be better understood with the aid of the additional description which follows, which refers to examples of culturing mollusc cells in a medium in accordance with the invention.
- Example 1 Preparation of the culture media
- the basic medium used is a commercial medium, for example LEIBOVITZ L-15 medium (SEROMED), enriched with mineral salts.
- SEROMED LEIBOVITZ L-15 medium
- the composition of a complete basic medium which can be used is indicated by way of example in Table I below:
- a defined supplement in accordance with the invention is added in the form of a concentrated FPL stock solution, prepared in advance, distributed in aliquots and stored at ⁇ 20 ° C.
- composition of this stock solution is indicated in Table II below:
- the cell viability test chosen is the assay for the reduction of MTT ((-3- (4,5-dimethylthiazol-2-yl) -2,5 diphenyl tetrazolium bromide) by the mitochondrial succinate dehydrogenases of living cells.
- the quantity of formazan formed (OD 570 n / OD 630 nm) is directly proportional to the number of viable cells in culture. This linearity is respected over 24 h for a range of 0.1 to 1.5 ⁇ 10 ° viable cells / ml.
- the ability of cells to reduce MTT is specific to a given cell population, in a given physiological state. This capacity varies during the cultures.
- the heart cells of C. gigas oyster were cultivated, in primary cultures from explants, or in secondary cultures, in different media, respectively: a) basic medium; b) basic medium supplemented with 10% v / v of undefined supplement (fetal calf serum); c) base medium supplemented with 10% v / v of stock solution of defined supplement FPL; d) base medium supplemented with 10% v / v of stock solution of defined supplement FPL, and 10% v / v of undefined supplement (fetal calf serum).
- the defined supplement in accordance with the invention increases the mitochondrial activity of cells in culture in vitro, and also acts in synergy with other " supplements such as fetal calf serum. Metabolic activation is also accompanied by particularly significant cell proliferation during the second month of culture It therefore appears that the defined supplement in accordance with the invention makes it possible to improve the viability and proliferation capacities of adult cell cultures differentiated from marine invertebrates.
- Secondary cultures were carried out by trypsinization and subculturing of adherent cells coming from primary cultures in explants aged either 7 days (1st experiment), or 14 days (2nd experiment).
- the subcultured cells were seeded in secondary culture in T-25 CORNING flasks at 40-45,000 cells / cm 2 , in 2 ml of medium supplemented by the combination of 10% FCS and 10% FPL.
- the cultures were incubated at 20 ° C., either under 20% of 0 2 , or under 2% of 0 2 .
- Their evolution was followed over time, by morphological observation, and by enumeration of all cells on the Malassez slide and trypan test: cell types present, total number of viable cells excluding trypan blue, and cell adhesion.
- the first experiment was followed over 43 days.
- the second experiment was followed over 28 days.
- the secondary cultures produced at 20% and 2% 0 contain the same cell types: amoebocyte type cells, epitheliocyte type cells and fibroblastic (contractile) cells.
- the first experience highlights a difference 'survival as the cultures were incubated with 2 or 20% 0 2: during the first two weeks of culture, the viable cell density decreases in both 20% 0 2 and under 2% of 0: around 60% of surviving cells remain after 14 days; then the density of viable cells increases, slightly (+ 25%) and from 28 days in cultures incubated with 20% O 2 , more strongly (+ 50%) and from the 14th day on in cultures incubated with 2 % of 0; after 43 days, there remains under 2% of O 2 about 90% of surviving cells, while under 20% of O 2 there remains only about 60%.
- the second experiment confirms this difference in survival observed between secondary cultures incubated under 20% O 2 and under 2% O 2 : after 28 days, there remains under 2% O 2 approximately 50% of cells. survivors, whereas under 20% of 0 2 , only about 40% remain.
- the reduction of the partial pressure in O 2 therefore improves the survival of the secondary cultures of oyster heart cells: it accelerates and amplifies the phenomenon of transient growth observed during the second month of culture in medium supplemented by the association 10% of SVF and 10% FPL.
- a third experiment of secondary culture under 20% or under 2% of O 2 was carried out, in medium not containing FPL, in order to see if the response of the oyster cells to the decrease in the partial pressure in 0 2 depends on the composition of the medium in which they were cultivated, and in particular on the presence of the FPL supplement.
- Secondary cultures were carried out by trypsinization and subculturing of adherent cells from primary cultures in explants aged 14 days.
- the subcultured cells were seeded in secondary culture in T-25 CORNING flasks at 65,000 cells / cm 2 , in 2 ml of medium supplemented with FCS but not supplemented with FPL.
- the cultures were incubated at 20 ° C., either under 20% of 0, or under 2% of 0 2 .
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
MILIEUX DE CULTURE POUR DES CELLULES D'INVERTEBRES MARINS. CULTURE MEDIA FOR MARINE INVERTEBRATE CELLS.
L'Invention est relative à de nouveaux milieus de culture cellulaire convenant pour des cultures de cellules d'invertébrés marins, en particulier pour des cultures de cellules de mollusques.The invention relates to new cell culture media suitable for cell culture of marine invertebrates, in particular for cell culture of molluscs.
Les cultures de cellules d'invertébrés sont apparues dans les années 1930. Elles se sont principale¬ ment orientés vers les cultures de cellules d'insectes, en raison de leurs nombreuses applications en virologie et en pathologie. Ces cultures ont depuis connu un grand essor et sont maintenant pratiquées à l'échelle indus¬ trielle pour la production de protéines recombinantes (système à baculovirus) . II n'en va pas de même pour les autres inver¬ tébrés, et particulièrement pour les mollusques ; les tentatives de culture de cellules de mollusques ont été assez nombreuses, mais ponctuelles et peu suivies ; peu d'espèces ont été mises en culture, et les travaux entre- pris n'ont pas abouti à la mise au point d'un milieu de culture autorisant une prolifération cellulaire signifi¬ cative in vi tro .Invertebrate cell cultures first appeared in the 1930s. They were mainly oriented towards insect cell cultures, due to their numerous applications in virology and pathology. These cultures have since grown rapidly and are now used on an industrial scale for the production of recombinant proteins (baculovirus system). It is not the same for other inver¬ tebrates, and particularly for molluscs; attempts to culture mollusc cells have been quite numerous, but punctual and little followed; few species have been cultured, and the work undertaken has not resulted in the development of a culture medium allowing significant cell proliferation in vitro.
Les premiers milieux de culture de cellules de mollusques marins, se composaient d'eau de mer filtrée, tamponnée, et additionnée d'antibiotiques, de glucides et d'azote sous forme d'acides aminés ou d'extrait de protéines [VAGO et CHASTANG, C.R. Acad. Sci. , 250, 2751-2753 (i960)].The first culture media for marine mollusc cells consisted of filtered, buffered seawater, supplemented with antibiotics, carbohydrates and nitrogen in the form of amino acids or protein extract [VAGO and CHASTANG , CR Acad. Sci. , 250, 2751-2753 (i960)].
Puis des connaissances analytiques sur la compositions de l 'hémolymphe (le fluide extracellulaire baignant les cellules des invertébrés) ont été acquises, et la composition des milieux de cultures a été calquée sur la composition de l 'hémolymphe : le milieu de culture est la reconstitution artificielle la plus fidèle possible de la composition organique et minérale et des caractéristiques physico-chimiques de l'hémolymphe de l'animal mis en culture [CHERNIN, J. Parasitol., 49, 353-364 (1963) ] .Then analytical knowledge on the composition of the hemolymph (the extracellular fluid bathing the cells of invertebrates) was acquired, and the composition of the culture media was modeled on the composition of the hemolymph: the culture medium is the reconstitution as faithful as possible to the organic and mineral composition and the physicochemical characteristics of the hemolymph of the animal placed in culture [CHERNIN, J. Parasitol., 49, 353-364 (1963)].
Cependant, la composition de l'hemolymphe varie entre les divers groupes d'invertébrés, et au sein d'un même genre, entre les espèces. Cette composition présente en outre une grande variabilité intraspéci- fique : la composition de l'hemolymphe d'huître varie par exemple en fonction des saisons et de l'habitat.However, the composition of the hemolymph varies between different groups of invertebrates, and within the same genus, between species. This composition also has great intraspecific variability: the composition of the oyster hemolymph varies, for example, depending on the season and the habitat.
Il faut donc préalablement à toute mise en culture, étudier au préalable et de manière très complète la composition de l'hemolymphe de chaque espèce mise en culture, ce qui implique un travail analytique prélimi¬ naire très complexe et très lourd. De plus, les milieux mis au point par cette méthode doivent être modifiés à chaque changement d'espèce cultivée. Un effort de standardisation des milieux de culture de cellules d'invertébrés a été entrepris en 1969 par VAGO et QUIOT [Ann. Zool. Ecol. Anim. , 1, 281-288 (1969)] .It is therefore necessary, prior to any cultivation, to study beforehand and very completely the composition of the hemolymph of each species cultivated, which implies very complex and very heavy preliminary analytical work. In addition, the environments developed by this method must be modified with each change of cultivated species. An effort to standardize culture media for invertebrate cells was undertaken in 1969 by VAGO and QUIOT [Ann. Zool. School. Anim. , 1, 281-288 (1969)].
Ils ont établi différentes formulations, sur la base du rapport Na/K, de la pression osmotique et du pH de l'hemolymphe des espèces cultivées. Les milieux de culture ainsi mis au point se décomposent ainsi en :They established different formulations, based on the Na / K ratio, the osmotic pressure and the pH of the hemolymph of the cultivated species. The culture media thus developed break down as follows:
- une partie constante comprenant une fraction organique (glucides, lipides et acides aminés), des anti- biotiques, et des sérums apportant des vitamines et des facteurs de croissance non spécifiques.- a constant part comprising an organic fraction (carbohydrates, lipids and amino acids), antibiotics, and serums providing vitamins and non-specific growth factors.
- une partie qui varie en fonction des espèces mises en culture, comprenant une fraction minérale (sels minéraux en proportions spécifiques, permettant d'ajuster la pression osmotique à la valeur désirée) , une fraction spéciale (vitamines et facteurs de croissance spéci¬ fiques), et une fraction permettant de tamponner le pH à la valeur désirée.- a part which varies according to the species cultivated, comprising a mineral fraction (mineral salts in specific proportions, making it possible to adjust the osmotic pressure to the desired value), a special fraction (specific vitamins and growth factors) , and a fraction allowing the pH to be buffered to the desired value.
Les caractéristiques physico-chimiques des milieux respectent celles de l'hemolymphe des espèces cultivées : pour les mollusques marins, les cellules sont généralement cultivées entre 15" et 25*C, à un pH variant entre 6,8-7,0 et 7,2-7,4 et à la même pression osmotique que celle de l'hemolymphe, soit entre 900 et 1100 mosmol/1. Les suppléments de culture utilisés sont très variés : suppléments dit "indéfinis", dont la composition chimique n'est pas précisée, tels que l'hemolymphe homo¬ logue ou hétérologue inactivée, à 5 ou 10%, le sérum de veau foetal à 10%, le sérum bovin, le sérum de cheval, les extraits d'organes ou d'animaux entiers, les extraits embryonnaires de poulet, ou suppléments dits "définis" tels que : hydrolysats protéiques, acides aminés, vita¬ mines, facteurs de croissance spécifiques ou non spécifiques, etc.. Bien que les suppléments cités-ci dessus soient couramment utilisés pour les cultures de cellules de vertébrés, leur utilisation pour la culture des cellules d'invertébrés marins n'avait jusqu'à présent, pas abouti à des résultats satisfaisants. Ceci s'explique par le fait que les cellules des invertébrés marins vivent dans des conditions naturelles très différentes de celles des vertébrés. Les invertébrés marins et plus particulièrement les mollusques bivalves ne possèdent pas de milieu intérieur proprement dit, et ne sont pas capables d'homeostasie. Ils ont des systèmes enzymatiques spécifiques, adaptés à des températures plus basses (15- 20*C) et à des pressions plus élevées ; les substrats n'ont pas les mêmes affinités pour ces enzymes que pour des enzymes de vertébrés. (Km, etc...) . D'autre part, pour reproduire le plus possible la composition de l'hemolymphe, les cultures sont effectuées en milieux hyperosmotiques : (1100 mosmol/1, soit 3 à 4 fois plus que l'osmolarité classique des milieux pour vertébrés qui est d'environ 300 mosmol/1) . Afin d'atteindre cette osmolarité, la salinité des milieux est portée jusqu'à environ 35 g/1 de sels dissous. Or, il est connu qu'en conditions hypersalines, la perméabilité des membranes est altérée, et des capacités d'échange entre les cellules et leur environnement diminuées.The physico-chemical characteristics of the environments respect those of the hemolymph of cultivated species: for marine molluscs, the cells are generally cultivated between 15 "and 25 * C, at a pH varying between 6.8-7.0 and 7.2-7.4 and at the same osmotic pressure as that of the hemolymph, ie between 900 and 1100 mosmol / 1. The culture supplements used are very varied: so-called "indefinite" supplements, the chemical composition of which is not specified, such as the homologous or heterologous hemolymph inactivated, at 5 or 10%, fetal calf serum at 10%, bovine serum, horse serum, extracts of organs or whole animals, embryonic chicken extracts, or so-called "defined" supplements such as: protein hydrolysates, amino acids, vitamins, factors specific or non-specific growth, etc. Although the supplements mentioned above are commonly used for vertebrate cell cultures, their use for the culture of marine invertebrate cells has so far been unsuccessful to satisfactory results. This is explained by the fact that the cells of marine invertebrates live in natural conditions very different from those of vertebrates. Marine invertebrates and more particularly bivalve molluscs do not have an interior environment proper, and are not capable of homeostasis. They have specific enzyme systems, adapted to lower temperatures (15- 20 ° C) and at higher pressures; the substrates do not have the same affinities for these enzymes as for vertebrate enzymes. (Km, etc ...). On the other hand, to reproduce as much as possible the composition of the hemolymph, the cultures are carried out in hyperosmotic environments: (1100 mosmol / 1, or 3 to 4 times more than the conventional osmolarity of the environments for vertebrates which is about 300 mosmol / 1). In order to achieve this osmolarity, the salinity of the media is brought to about 35 g / l of dissolved salts. However, it is known that hypersaline conditions, the permeability of the membranes is impaired, and the exchange capacities between the cells and their environment reduced.
Les conditions de culture satisfaisantes pour les cellules de vertébrés, ne sont donc a priori pas transposables à la culture des cellules d'invertébrés marins.The satisfactory culture conditions for vertebrate cells cannot therefore be transposed a priori to the culture of marine invertebrate cells.
Certains milieux, répondant plus spécifiquement aux besoins de certains types de cellules d'invertébrés marins ont été mis au point ; la Demande PCT US 88/03325 décrit par exemple, un procédé de culture permettant de maintenir en vie des cellules d'expiants de manteaux d'huîtres destinés à la production perlière, dans un milieu comprenant une solution saline simulant le milieu naturel associé au tissu du manteau d'huître ; des acides aminés, des sucres assimilables, et un supplément tel que de l'hemolymphe, des extraits de gonade de mollusques, un extrait de levure ou du sérum de veau foetal. L'utilisation de tels milieux permet le main¬ tien en cultures primaires de cellules adultes, donc différenciées, de mollusques, pendant des périodes allant de quelques jours à plusieurs mois. Toutefois, ces cultures ne présentent pas de figures de mitoses, ou très peu et uniquement durant les premiers temps de la culture. L'index mitotique des cellules est très faible : 1"/*' dans les cultures de cellules de corps blanc d ' Octopus vulgaris et 1 à 5*/"' dans les cultures de cellules somatiques de Bivalves marins. Les cultures primaires issues d'expiants contiennent des cellules en suspension et des cellules adhérentes, qui forment un tapis confluent au bout de 7 à 15 jours de culture. A partir des cellules en suspension, des cellules adhérentes, ou de l'ensemble des cellules des cultures primaires, l'obtention de cultures secondaires a été tentée. Toutefois, les cultures secondaires ne forment pas de tapis confluent et ne peuvent donc pas être à nouveau repiquées ; elles peuvent uniquement être maintenues en survie pendant des périodes allant de quelques jours à plusieurs semaines in vi tro, sans proliférer de manière significative ; leur maintenance dépend des conditions de culture (présence/absence des expiants, densité d'ensemencement, ...) et des caractéristiques des milieux de culture utilisés.Certain environments, more specifically responding to the needs of certain types of marine invertebrate cells, have been developed; PCT Application US 88/03325 describes, for example, a culture process allowing cells of explants from oyster coats intended for pearl production to be kept alive, in a medium comprising a saline solution simulating the natural medium associated with the tissue oyster coat; amino acids, assimilable sugars, and a supplement such as hemolymph, mollusc gonad extracts, yeast extract or fetal calf serum. The use of such media allows maintenance in primary cultures of adult cells, therefore differentiated, of molluscs, for periods ranging from a few days to several months. However, these cultures do not show mitotic figures, or very few and only during the early days of culture. The mitotic cell index is very low: 1 "/ * 'in white body cell cultures of Octopus vulgaris and 1 to 5 * /"' in somatic cell cultures of Marine Bivalves. Primary cultures from explants contain cells in suspension and adherent cells, which form a confluent carpet after 7 to 15 days of culture. From suspended cells, adherent cells, or from all of the primary culture cells, attempts have been made to obtain secondary cultures. However, secondary crops do not form no carpet converges and therefore cannot be transplanted again; they can only be kept alive for periods ranging from a few days to several weeks in vitro, without proliferating significantly; their maintenance depends on the culture conditions (presence / absence of explants, seeding density, ...) and the characteristics of the culture media used.
A la différence des cellules adultes, les cellules de larves de Crassostrea gigas et de Crassostrea virginica semblent se diviser activement en culture primaire. Les cellules de larves de Biomphalaria glabrata se divisent activement et peuvent être repiquées pendant plusieurs générations. Leur culture s'est cependant toujours faite sur de courtes -périodes, suite à des contaminations qui apparaissaient et se développaient rapidement aux dépens des cellules cultivées.Unlike adult cells, the cells of Crassostrea gigas and Crassostrea virginica larvae appear to divide actively in primary culture. Biomphalaria glabrata larva cells actively divide and can be transplanted for several generations. However, their culture was always carried out over short periods, following contaminations which appeared and developed rapidly at the expense of the cultured cells.
La présente Invention, qui a été réalisée par la Demanderesse en collaboration avec le Laboratoire de Biologie des Invertébrés Marins du Muséum d'Histoire Naturelle, s'est fixé pour but de fournir des milieux de culture répondant mieux que les milieux de l'art anté¬ rieur aux besoins des cellules d'invertébrés marins, en particulier de mollusques, et permettant la culture de cellules adultes, en assurant une survie plus longue, et une meilleure prolifération de ces cellules en culture et en particulier en cultures secondaires.The present invention, which was produced by the Applicant in collaboration with the Laboratory of Marine Invertebrate Biology of the Museum of Natural History, has set itself the goal of providing culture media which respond better than the media of ancient art. ¬ laughing at the needs of marine invertebrate cells, in particular molluscs, and allowing the culture of adult cells, ensuring longer survival, and better proliferation of these cells in culture and in particular in secondary cultures.
Pour cela, l'Inventeur a mis au point un milieu de culture qui comprend, outre un milieu minéral et organique de base, un nouveau supplément, dénommé ci- après "supplément défini", et éventuellement, un supplément dit "indéfini" (c'est-à-dire un supplément de type sérum ou hémolymphe, dont la composition chimique exacte ne peut pas être déterminée avec précision) . Les constituants du supplément défini conforme à l'invention ont déjà été décrits, parmi d'autres, comme actifs sur la croissance de cellules en culture, dans le cas de cellules de mammifères et d'autres vertébrés. Toutefois, l'association de ces constituants n'avait jamais été proposée auparavant, pas plus qu'il n'avait été suggéré qu'ils puissent avoir un effet favorable sur la viabilité des cultures de cellules d'invertébrés marins, et en particulier de mollusques.For this, the inventor has developed a culture medium which comprises, in addition to a basic mineral and organic medium, a new supplement, hereinafter called "defined supplement", and possibly, a so-called "indefinite" supplement (c (i.e. a serum or hemolymph supplement, the exact chemical composition of which cannot be determined with precision). The constituents of the defined supplement according to the invention have already been described, among others, as active on the growth of cells in culture, in the case of cells of mammals and other vertebrates. However, the association of these constituents had never been proposed before, nor had it been suggested that they could have a favorable effect on the viability of the cultures of cells of marine invertebrates, and in particular of molluscs.
La présente Invention a pour objet une compo¬ sition utilisable comme supplément défini pour un milieu de culture cellulaire destiné à la culture des inverté¬ brés marins, laquelle composition est caractérisée en ce qu'elle comprend, au moins une hormone choisie dans le groupe comprenant l'insuline, les IGF (Insuline like Growth Factor), 1'hydrocortisone et les glycocorticoides, au moins un facteur de croissance choisi dans le groupe comprenant l'EGF (Epidermal Growth Factor), le FGF (Fibroblast Growth Factor), et le PDGF (Platelet Derived Growth Factor) , au moins une substance ou un extrait lipidique choisie dans le groupe comprenant l'Ex-Cyte VLE, l'extrait de jaune d'oeuf, et la prostaglandine F2α, et au moins un agent protecteur choisi parmi les inhibiteurs de radicaux libres.The subject of the present invention is a composition which can be used as a defined supplement for a cell culture medium intended for the culture of marine invertebrates, which composition is characterized in that it comprises, at least one hormone chosen from the group comprising insulin, IGF (Insulin like Growth Factor), hydrocortisone and glycocorticoids, at least one growth factor chosen from the group comprising EGF (Epidermal Growth Factor), FGF (Fibroblast Growth Factor), and PDGF (Platelet Derived Growth Factor), at least one lipid substance or extract chosen from the group comprising Ex-Cyte VLE, egg yolk extract, and prostaglandin F2α, and at least one protective agent chosen from free radical inhibitors.
Selon un mode de réalisation préféré du supplément défini pour cultures cellulaires conforme à l'Invention, il comprend entre 10 et 100 μg/ml d'insuline bovine, entre 10~^ et 10~4 M d'hydrocortisone, entre 5 et 50 ng/ml de EGF, entre 1 et 25 ng/ml de PDGF, entre 0,2 et 2% (v/v) d'extrait de jaune d'oeuf, entre 0,05 et 0,2% v/v d'Ex-cyte VLE, entre 10~9 et 2 x 10~8M de prostaglandine F2α, entre 10 et 100 μg/ml de catalase.According to a preferred embodiment of the supplement defined for cell cultures in accordance with the invention, it comprises between 10 and 100 μg / ml of bovine insulin, between 10 ~ ^ and 10 ~ 4 M hydrocortisone, between 5 and 50 ng / ml of EGF, between 1 and 25 ng / ml of PDGF, between 0.2 and 2% (v / v) of egg yolk extract, between 0.05 and 0.2% v / v of Ex-cyte VLE, between 10 ~ 9 and 2 x 10 ~ 8 M prostaglandin F2α, between 10 and 100 μg / ml of catalase.
L'Inventeur a en outre constaté que l'effet du supplément défini conforme à l'Invention était consi¬ dérablement augmenté lorsque ledit supplément est associé à un supplément de type "indéfini" tel que du sérum de veau foetal, ou de l'hemolymphe d'huître. L'Invention englobe également des milieux de cultures cellulaires adaptés à la culture de cellules d'invertébrés marins, en particulier de mollusques, lesquels milieux sont caractérisés en ce qu'ils comprennent un milieu de base comprenant des sels minéraux, des sucres, des acides aminés, et des vitamines, auquel est additionné un supplément défini pour cultures cellulaires conforme à l'Invention.The inventor further noted that the effect of the supplement defined in accordance with the invention was considerably increased when the said supplement was combined with a supplement of the "indefinite" type such as fetal calf serum or hemolymph. oyster. The invention also encompasses cell culture media suitable for the culture of marine invertebrate cells, in particular molluscs, which media are characterized in that they comprise a basic medium comprising mineral salts, sugars, acids amino, and vitamins, to which is added a defined supplement for cell cultures in accordance with the invention.
Selon un mode de réalisation préféré des milieux de cultures cellulaires conforme à l'Invention, ils comprennent en outre un supplément indéfini choisi dans le groupe constitué par le sérum de veau foetal ou l'hemolymphe d'huître.According to a preferred embodiment of the cell culture media in accordance with the invention, they also comprise an indefinite supplement chosen from the group consisting of fetal calf serum or oyster hemolymph.
Les milieux conformes à l'Invention sont constitués par exemple d'une base minérale et organique du commerce (RPMI 1640, LEIBOVITZ L-15, ...) à laquelle sont ajoutés des sels minéraux (NaCl, KC1, CaCl2, MgCl2, MgSθ4) , des antibiotiques (pénicilline, streptomycine) et des suppléments de composition indéfinie (sérum de veau foetal, hémolymphe, ...) et un supplément de composition définie conforme à l'Invention.The media in accordance with the invention consist for example of a commercial mineral and organic base (RPMI 1640, LEIBOVITZ L-15, etc.) to which mineral salts are added (NaCl, KC1, CaCl2, MgCl 2 , MgSθ4), antibiotics (penicillin, streptomycin) and supplements of indefinite composition (fetal calf serum, hemolymph, ...) and a supplement of defined composition in accordance with the invention.
La présente Invention a en outre pour objet un procédé de cultures de cellules d'invertébrés marins, caractérisé en ce que lesdites cellules sont cultivées dans un milieu comprenant le supplément défini conforme à 1'invention.The present invention further relates to a method of culturing marine invertebrate cells, characterized in that said cells are cultured in a medium comprising the defined supplement according to the invention.
L'Inventeur a également constaté que le développement et la survie des cultures de cellules d'invertébrés marins sont encore améliorées lorsque l'utilisation de milieux de culture comprenant le supplément défini conforme à l'Invention, est combinée avec la culture des cellules sous atmosphère pauvre en oxygène.The inventor also found that the development and survival of cultures of marine invertebrate cells are further improved when the use of culture media comprising the defined supplement in accordance with the invention is combined with the culture of cells in an atmosphere. poor in oxygen.
Selon un mode de mise en oeuvre préféré du procédé de culture de cellules d'invertébrés marins conforme à l'Invention, lesdites cellules sont cultivées sous atmosphère contenant moins de 10% d'oxygène.According to a preferred embodiment of the method of culturing marine invertebrate cells according to the invention, said cells are cultured under an atmosphere containing less than 10% oxygen.
Selon une modalité avantageuse de ce mode de mise en oeuvre, les cellules sont cultivées sous atmosphère comtenant moins de 5% d'oxygène. Le supplément défini conforme à la présente invention présente, par rapport aux suppléments de l'art antérieur, les avantages suivants : il améliore la viabilité à court terme et la survie à long terme des cultures de cellules d'invertébrés marins ; il peut remplacer le sérum de veau foetal dans ces cultures, et agit en synergie avec celui-ci sur l'amélioration de la viabilité et de la survie cellulaire ; son effet est augmenté par la réduction de la pression partielle en oxygène. La présente Invention sera mieux comprise à l'aide du complément de description qui va suivre, qui se réfère à des exemples de mise en culture de cellules de mollusques dans un milieu conforme à l'Invention.According to an advantageous modality of this mode of implementation, the cells are cultured under an atmosphere containing less than 5% oxygen. The defined supplement in accordance with the present invention has the following advantages over supplements of the prior art: it improves the short-term viability and the long-term survival of cultures of marine invertebrate cells; it can replace fetal calf serum in these cultures, and acts in synergy with it to improve cell viability and survival; its effect is increased by the reduction of the partial oxygen pressure. The present invention will be better understood with the aid of the additional description which follows, which refers to examples of culturing mollusc cells in a medium in accordance with the invention.
Il va de soi toutefois que ces exemples sont donnés uniquement à titre d'illustration de l'objet de l'Invention, dont ils ne constituent en aucune manière une limitation.It goes without saying, however, that these examples are given solely by way of illustration of the subject of the invention, of which they in no way constitute a limitation.
Les expérimentations décrites ci-dessous ont été effectuées sur des cultures de cellules de coeur d'huître creuse Crassostrea gigas .The experiments described below were carried out on cultures of hollow oyster Crassostrea gigas heart cells.
Exemple 1 : Préparation des milieux de culture Le milieu de base utilisé est un milieu com¬ mercial, par exemple du milieu LEIBOVITZ L-15 (SEROMED) , enrichi en sels minéraux. La composition d'un milieu de base complet utilisable est indiquée à titre d'exemple dans le tableau I suivant :Example 1: Preparation of the culture media The basic medium used is a commercial medium, for example LEIBOVITZ L-15 medium (SEROMED), enriched with mineral salts. The composition of a complete basic medium which can be used is indicated by way of example in Table I below:
TABLEAU I TABLE I
TABLEAU I (suite) TABLE I (continued)
ACIDES AMINES g/iAMINO ACIDS g / i
L-Alanine 0,225 L-Arginine 0,5 L-Aspargine 0,25 L-Cystéine 0,12 Glycine 0,2 L-Histidine 0,25 L-Isoleucine 0,125 L-Leucine 0,125 L-Lysine 0,075 L-Méthionine 0,075 L-Phénylalanine 0,125 L-Sérine 0,2 L-Thréonine 0,3 L-Tryptophane 0,02 L-Tyrosine 0,3 L-Valine 0,1 L-Glutamine 0,294 (au moment de l'emploi)L-Alanine 0.225 L-Arginine 0.5 L-Aspargine 0.25 L-Cysteine 0.12 Glycine 0.2 L-Histidine 0.25 L-Isoleucine 0.125 L-Leucine 0.125 L-Lysine 0.075 L-Methionine 0.075 L- Phenylalanine 0.125 L-Serine 0.2 L-Threonine 0.3 L-Tryptophan 0.02 L-Tyrosine 0.3 L-Valine 0.1 L-Glutamine 0.294 (at time of use)
A ce milieu, on ajoute un supplément défini conforme à 1'Invention sous forme de solution-stock FPl concentrée, préparée à l'avance, répartie en aliquots et conservée à -20"C.To this medium, a defined supplement in accordance with the invention is added in the form of a concentrated FPL stock solution, prepared in advance, distributed in aliquots and stored at −20 ° C.
La composition de cette solution stock est indiquée dans le tableau II suivant : The composition of this stock solution is indicated in Table II below:
TABLEAU IITABLE II
En outre, l'un ou l'autre des suppléments indéfinis suivants peuvent être ajoutés au milieu :In addition, any of the following undefined supplements can be added to the middle:
- Sérum de Veau Foetal (SVF) [PAA GmbH] décomplémenté par chauffage pendant 30' à 56*C, ou bien- Fetal Calf Serum (SVF) [PAA GmbH] decomplemented by heating for 30 'at 56 * C, or
- Hémolymphe homologue [hémolymphe d'huître creuse (C. gigas) prélevée par ponction de la cavité péricardique des huîtres durant l'hiver, (Octobre-Mars), filtrée sur 0,2 μm et congelée à -20'C], inactivée par chauffage pendant 30' à 56 *C) .- Homologous hemolymph [hemolymph of hollow oyster (C. gigas) taken by puncture of the pericardial cavity of oysters during winter, (October-March), filtered through 0.2 μm and frozen at -20 ° C], inactivated by heating for 30 'at 56 * C).
Le pH des milieux est ajusté à 7,0-7,5, leur pression osmotique à 1000-1100 mosmol/1 et les cultures sont incubées à 18-25 ' C sous air : 80% N2, 20% 02, 0,03% C02 (v/v) . Exemple 2 : Effet du supplément FPl sur la viabilité des cellules en cultureThe pH of the media is adjusted to 7.0-7.5, their osmotic pressure at 1000-1100 mosmol / 1 and the cultures are incubated at 18-25 ° C in air: 80% N 2 , 20% 0 2 , 0 , 03% C0 2 (v / v). Example 2 Effect of the FPL Supplement on the Viability of the Cells in Culture
- Test de viabilité cellulaire- Cell viability test
Le test de viabilité cellulaire choisi est le dosage de la réduction du MTT (bromure de (-3-(4,5-diméthylthiazol-2-yl)-2,5 diphényl tétrazolium) par les succinate-déshydrogénases mitochondriales des cellules vivantes.The cell viability test chosen is the assay for the reduction of MTT ((-3- (4,5-dimethylthiazol-2-yl) -2,5 diphenyl tetrazolium bromide) by the mitochondrial succinate dehydrogenases of living cells.
Ce test est effectué selon le protocole suivant :This test is carried out according to the following protocol:
Les cellules sont ajustées à des dilutions successives dans le milieu de culture et ensemencées dans des microplaques de 96 puits : 100 μl de suspension cellulaire/puit, 3 répétitions/dilution ; 10 μl d'une solution de MTT à 5 mg/ml dans PBS sont ajoutés à chaque puits ; la microplaque est incubée 6 h à 20 'C ; 100 μl d'HCl 0,04 N dans isopropanol sont ajoutés dans chaque puits ; la plaque est agitée 10 minutes ; la DO (densité optique) est lue à λ = 570 n contre λ réf. = 630 mn. Seules des cellules vivantes peuvent réduire le MTT en formazan. A un instant donné et dans un état physiologique donné, la quantité de formazan formée (DO 570 n /DO 630 nm) est directement proportionnelle au nombre de cellules viables en culture. Cette linéarité est respectée sur 24 h pour une gamme de 0,1 à 1,5.10° cellules viables/ml.The cells are adjusted to successive dilutions in the culture medium and seeded in 96-well microplates: 100 μl of cell suspension / well, 3 repetitions / dilution; 10 μl of a solution of MTT at 5 mg / ml in PBS are added to each well; the microplate is incubated for 6 h at 20 ° C; 100 μl of 0.04 N HCl in isopropanol are added to each well; the plate is stirred for 10 minutes; the OD (optical density) is read at λ = 570 n against λ ref. = 630 min. Only living cells can reduce MTT to formazan. At a given instant and in a given physiological state, the quantity of formazan formed (OD 570 n / OD 630 nm) is directly proportional to the number of viable cells in culture. This linearity is respected over 24 h for a range of 0.1 to 1.5 × 10 ° viable cells / ml.
La capacité des cellules à réduire le MTT (dDO/d nombre de cellules viables) est spécifique d'une population de cellules donnée, dans un état physiologique donné. Cette capacité varie au cours des cultures.The ability of cells to reduce MTT (dDO / d number of viable cells) is specific to a given cell population, in a given physiological state. This capacity varies during the cultures.
Ce test apporte donc une indication globale sur le nombre, l'activité et la viabilité des cellules en culture ; il permet de distinguer entre mort, survie et prolifération des cellules ; il permet de mesurer une activation cellulaire, même en l'absence de prolifération. - Etude de l'effet du supplément FPlThis test therefore provides an overall indication of the number, activity and viability of the cells in culture; it makes it possible to distinguish between death, survival and proliferation of cells; it makes it possible to measure cell activation, even in the absence of proliferation. - Study of the effect of the FPL supplement
Les cellules de coeur d'huître C. gigas ont été cultivées, en cultures primaires à partir d'expiants, ou bien en cultures secondaires, dans des milieux différents, respectivement : a) milieu de base ; b) milieu de base additionné de 10% v/v de supplément indéfini (sérum de veau foetal) ; c) milieu de base additionné de 10% v/v de solution stock de supplément défini FPl ; d) milieu de base additionné de 10% v/v de solution stock de supplément défini FPl, et de 10% v/v de supplément indéfini (sérum de veau foetal) .The heart cells of C. gigas oyster were cultivated, in primary cultures from explants, or in secondary cultures, in different media, respectively: a) basic medium; b) basic medium supplemented with 10% v / v of undefined supplement (fetal calf serum); c) base medium supplemented with 10% v / v of stock solution of defined supplement FPL; d) base medium supplemented with 10% v / v of stock solution of defined supplement FPL, and 10% v / v of undefined supplement (fetal calf serum).
Le comportement des cellules dans ces différents milieux a été déterminé :The behavior of cells in these different media has been determined:
- sur les cellules en culture primaire, par l'observation de la morphologie cellulaire, l'évaluation de la migration et du rendement cellulaire total, et l'évaluation de la viabilité et de l'adhérence cellulaire.- on cells in primary culture, by observing cell morphology, evaluating migration and total cell yield, and evaluating cell viability and adhesion.
- sur les cellules en culture secondaire, par la mesure de la capacité des cellules à réduire le MTT (test MTT pratiqué selon le protocole décrit ci-dessus), ainsi que par l'observation de la morphologie cellulaire, l'évaluation de la densité, de la viabilité et de- on cells in secondary culture, by measuring the capacity of cells to reduce MTT (MTT test performed according to the protocol described above), as well as by observing cell morphology, assessing density , sustainability and
1 'adhérence cellulaire.Cell adhesion.
Les résultats sont les suivants :The results are as follows:
1) Capacité des cellules à réduire le MTT :1) Ability of cells to reduce MTT:
(test à court terme, sur 7 jours) - En présence de 10% de supplément FPl la capacité des cellules à réduire le MTT augmente de 25 à(short-term test, over 7 days) - In the presence of 10% FPL supplement, the cells' capacity to reduce MTT increases from 25 to
30% par rapport à celle observée avec le milieu de base ; en présence de 10% de sérum de veau foetal, la réponse est identique. - En présence de 10% de supplément FPl + 10% de sérum de veau foetal, la capacité des cellules à réduire le MTT augmente de 100%.30% compared to that observed with the base medium; in the presence of 10% fetal calf serum, the response is identical. - In the presence of 10% FPL supplement + 10% fetal calf serum, the ability of cells to reduce MTT increases by 100%.
2) Survie des cultures secondaires (test à long terme, sur 3 mois)2) Survival of secondary crops (long-term test, over 3 months)
- En présence de 10% de supplément FPl + 10% de sérum de veau foetal, il reste environ 40% de cellules survivantes au bout de 15 jours de culture, alors qu'il en reste moins de 30% lorsque les cultures sont effectuées dans le milieu de base sans supplément ; en outre, pendant le deuxième mois de culture, on observe une augmentation de 35 à 50% du nombre de cellules viables en présence de 10% de supplément FPl + 10% de sérum de veau foetal, alors qu'en présence de 10% de sérum de veau foetal seul, le nombre de cellules viables reste stable.- In the presence of 10% FPL supplement + 10% fetal calf serum, about 40% of surviving cells remain after 15 days of culture, while less than 30% remain when the cultures are carried out in the basic medium without supplement; in addition, during the second month of culture, an increase of 35 to 50% in the number of viable cells is observed in the presence of 10% of FPL supplement + 10% of fetal calf serum, while in the presence of 10% of fetal calf serum alone, the number of viable cells remains stable.
Le supplément défini conforme à 1'Invention augmente l'activité mitochondriale des cellules en culture in vitro, et agit en outre en synergie avec d'autres "suppléments tels que le sérum de veau foetal. L'activation métabolique s'accompagne en outre de la prolifération des cellules particulièrement significative au cours du deuxième mois de culture. Il apparaît donc que le supplément défini conforme à l'Invention permet d'améliorer la viabilité et les capacités de prolifération de cultures de cellules adultes différenciées des invertébrés marins.The defined supplement in accordance with the invention increases the mitochondrial activity of cells in culture in vitro, and also acts in synergy with other " supplements such as fetal calf serum. Metabolic activation is also accompanied by particularly significant cell proliferation during the second month of culture It therefore appears that the defined supplement in accordance with the invention makes it possible to improve the viability and proliferation capacities of adult cell cultures differentiated from marine invertebrates.
Exemple 3 : Effet de la réduction de la pression partielle en oxygène sur des cellules en culture secondaires en présence ou en l'abscence du supplément FPl.Example 3 Effect of Reducing the Partial Oxygen Pressure on Secondary Culture Cells in the Presence or Absence of the FPL Supplement
Des cultures secondaires ont été réalisées par trypsinisation et repiquage de cellules adhérentes provenant de cultures primaires en explants âgées soit de 7 jours (1ère expérience) , soit de 14 jours (2ème expérience) . Les cellules repiquées ont été ensemencées en culture secondaire dans des flacons T-25 CORNING à 40- 45000 cellules /cm2, dans 2 ml de milieu supplé enté par l'association 10% de SVF et 10% de FPl. Les cultures ont été incubées à 20'C, soit sous 20% d'02, soit sous 2% d'02. Leur évolution a été suivie au cours du temps, par observation morphologique, et par dénombrement de toutes cellules sur lame Malassez et test trypan : types cellulaires présents, nombre total de cellules viables excluant le bleu trypan, et adhérence cellulaire. La première expérience a été suivie sur 43 jours. La deuxième expérience a été suivie sur 28 jours.Secondary cultures were carried out by trypsinization and subculturing of adherent cells coming from primary cultures in explants aged either 7 days (1st experiment), or 14 days (2nd experiment). The subcultured cells were seeded in secondary culture in T-25 CORNING flasks at 40-45,000 cells / cm 2 , in 2 ml of medium supplemented by the combination of 10% FCS and 10% FPL. The cultures were incubated at 20 ° C., either under 20% of 0 2 , or under 2% of 0 2 . Their evolution was followed over time, by morphological observation, and by enumeration of all cells on the Malassez slide and trypan test: cell types present, total number of viable cells excluding trypan blue, and cell adhesion. The first experiment was followed over 43 days. The second experiment was followed over 28 days.
Les cultures secondaires réalisées sous 20% et sous 2% d'0 contiennent les mêmes types cellulaires : cellules de types amoebocyte, cellules de type épithéliocyte et cellules de type fibroblastique (contractiles) .The secondary cultures produced at 20% and 2% 0 contain the same cell types: amoebocyte type cells, epitheliocyte type cells and fibroblastic (contractile) cells.
La première expérience met en évidence une différence 'de survie selon que les cultures sont incubées à 2 ou à 20% d'02 : pendant les deux premières semaines de culture, la densité de cellules viables diminue à la fois sous 20% d'02 et sous 2% d'0 : il reste au bout de 14 jours environ 60% de cellules survivantes ; puis la densité de cellules viables augmente, légèrement (+25%) et à partir de 28 jours dans les cultures incubées sous 20% d'02, plus fortement (+50%) et dès le 14è jour dans les cultures incubées sous 2% d'0 ; au bout de 43 jours, il reste sous 2% d'02 environ 90% de cellules survivantes, alors que sous 20% d'02 il n'en reste qu'environ 60%.The first experience highlights a difference 'survival as the cultures were incubated with 2 or 20% 0 2: during the first two weeks of culture, the viable cell density decreases in both 20% 0 2 and under 2% of 0: around 60% of surviving cells remain after 14 days; then the density of viable cells increases, slightly (+ 25%) and from 28 days in cultures incubated with 20% O 2 , more strongly (+ 50%) and from the 14th day on in cultures incubated with 2 % of 0; after 43 days, there remains under 2% of O 2 about 90% of surviving cells, while under 20% of O 2 there remains only about 60%.
La deuxième expérience confirme cette différence de survie observée entre des cultures secondaires incubées sous 20% d'02 et sous 2% d'02 : au bout de 28 jours, il reste sous 2% d'02 environ 50% de cellules survivantes, alors que sous 20% d'02, il n'en reste qu'environ 40%. La réduction de la pression partielle en 02 améliore donc la survie des cultures secondaires de cellules de coeur d'huître : elle accélère et amplifie le phénomène de croissance transitoire observée pendant le deuxième mois de culture en milieu supplémenté par l'association 10% de SVF et 10% de FPl.The second experiment confirms this difference in survival observed between secondary cultures incubated under 20% O 2 and under 2% O 2 : after 28 days, there remains under 2% O 2 approximately 50% of cells. survivors, whereas under 20% of 0 2 , only about 40% remain. The reduction of the partial pressure in O 2 therefore improves the survival of the secondary cultures of oyster heart cells: it accelerates and amplifies the phenomenon of transient growth observed during the second month of culture in medium supplemented by the association 10% of SVF and 10% FPL.
Une troisième expérience de culture secondaire sous 20% ou sous 2% d'02 a été effectuée, dans du milieu ne contenant pas de FPl, afin de voir si la réponse des cellules d'huître à la diminution de la pression partielle en 02 dépend de la composition du milieu dans lequel elles étaient cultivées, et en particulier de la présence du supplément FPl.A third experiment of secondary culture under 20% or under 2% of O 2 was carried out, in medium not containing FPL, in order to see if the response of the oyster cells to the decrease in the partial pressure in 0 2 depends on the composition of the medium in which they were cultivated, and in particular on the presence of the FPL supplement.
Des cultures secondaires ont été réalisées par trypsinisa ion et repiquage de cellules adhérentes provenant de cultures primaires en explants âgées de 14 jours. Les cellules repiquées ont été ensemencées en culture secondaire dans des flacons T-25 CORNING à 65000 cellules/cm2, dans 2 ml de milieu supplémenté en SVF mais non supplémenté en FPl. Les cultures ont été incubées à 20"C, soit sous 20% d'0 , soit sous 2% d'02 .Secondary cultures were carried out by trypsinization and subculturing of adherent cells from primary cultures in explants aged 14 days. The subcultured cells were seeded in secondary culture in T-25 CORNING flasks at 65,000 cells / cm 2 , in 2 ml of medium supplemented with FCS but not supplemented with FPL. The cultures were incubated at 20 ° C., either under 20% of 0, or under 2% of 0 2 .
Leur évolution a été suivie au cours du temps, par observation morphologique et par dénombrement de toutes cellules sur lame Malassez et test trypan : types cellulaires présents, nombre total de cellules viables excluant le bleu trypan et adhérence cellulaire. Cette expérience a été suivie sur 43 jours.Their evolution was followed over time, by morphological observation and by counting all cells on the Malassez slide and trypan test: cell types present, total number of viable cells excluding trypan blue and cell adhesion. This experiment was followed over 43 days.
En l'absence du supplément FPl, l'évolution des cultures incubées sous 20% ou sous 2% d'0 est identique : il n'y a pas de croissance transitoire ; la densité de cultures viables diminue puis se stabilise à environ 40% de cellules survivantes au bout de 28 et de 43 jours de culture.In the absence of the FPL supplement, the evolution of the cultures incubated under 20% or under 2% of O is identical: there is no transient growth; the density of viable cultures decreases and then stabilizes at around 40% of surviving cells after 28 and 43 days of culture.
En l'absence de supplément FPl, la réduction de la pression partielle en 0 n'a donc pas d'effets sur la prolifération des cultures secondaires. En conclusion, la réduction de la pression en oxygène de l'atmosphère améliore le développement et la survie des cultures de cellules de coeur d'huître : en culture primaire en explants elle ralentit la migration des cellules et prolonge le maintien des types cellulaires épithéliocyte et fibroblastique, sans changer le rendement au bout de deux mois ; en culture secondaire elle accélère et amplifie le phénomène de croissance transitoire observé pendant le deuxième mois de culture en milieu supplémenté par 10% de SVF et 10% de FPl ; cette influence positive est observée en présence du supplément de culture FPl, mais pas en présence de sérum de veau foetal seul. In the absence of an FPL supplement, the reduction of the partial pressure to 0 therefore has no effect on the proliferation of secondary cultures. In conclusion, reducing the oxygen pressure in the atmosphere improves the development and survival of oyster heart cell cultures: in primary culture by explants it slows cell migration and prolongs the maintenance of epitheliocyte cell types and fibroblastic, without changing the yield after two months; in secondary culture it accelerates and amplifies the transitory growth phenomenon observed during the second month of culture in medium supplemented with 10% of FCS and 10% of FPL; this positive influence is observed in the presence of the FPL culture supplement, but not in the presence of fetal calf serum alone.
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9115146A FR2684686B1 (en) | 1991-12-06 | 1991-12-06 | CULTURE MEDIA FOR MARINE INVERTEBRATE CELLS. |
| FR91/15146 | 1991-12-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1993011224A1 true WO1993011224A1 (en) | 1993-06-10 |
Family
ID=9419751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/FR1992/001147 Ceased WO1993011224A1 (en) | 1991-12-06 | 1992-12-04 | Culture media for cells of marine invertebrates |
Country Status (2)
| Country | Link |
|---|---|
| FR (1) | FR2684686B1 (en) |
| WO (1) | WO1993011224A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2735146A1 (en) * | 1995-06-12 | 1996-12-13 | Biopredic | Culturing marine invertebrate cells |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3109584B1 (en) | 2020-04-27 | 2024-05-10 | Paulou Massat Sophie De | Microcompartment for cnidarian cell culture |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989002919A1 (en) * | 1987-09-28 | 1989-04-06 | Lee Dosuk | Method for culturing pearls |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6255078A (en) * | 1985-05-17 | 1987-03-10 | Nippon Koutai Kenkyusho:Kk | Additive for cell culture |
| JPH0292277A (en) * | 1988-09-27 | 1990-04-03 | Japan Synthetic Rubber Co Ltd | Culture medium for culturing animal cell |
| JPH0322972A (en) * | 1989-01-12 | 1991-01-31 | Ajinomoto Co Inc | Serum-free culture medium |
-
1991
- 1991-12-06 FR FR9115146A patent/FR2684686B1/en not_active Expired - Fee Related
-
1992
- 1992-12-04 WO PCT/FR1992/001147 patent/WO1993011224A1/en not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989002919A1 (en) * | 1987-09-28 | 1989-04-06 | Lee Dosuk | Method for culturing pearls |
Non-Patent Citations (8)
| Title |
|---|
| ANNALES DE ZOOLOGIE vol. 1, no. 3, 1969, FR pages 281 - 288 C. VAGO ET AL. 'Recherches sur la composition des milieux pour culture de cellules d'invertébrés' cité dans la demande * |
| AQUATIC SCIENCES AND FISHERIES ABSTRACTS (ASFA). CAMBRIDGE SCIENTIFIC ABSTRACTS, BETHESDA, MD, US.; ABSTRACT NO. 113-02740 I.V. DERIKOT ET AL. 'In vitro culture of somatic cells of marine molluscs and echinoderms (Methodology)' * |
| AQUATIC SCIENCES AND FISHERIES ABSTRACTS (ASFA). CAMBRIDGE SCIENTIFIC ABSTRACTS, BETHESDA, MD, US.; ABSTRACT NO. 121-21176 I. DOMART ET AL. 'The use of a tetrazolium MTT reduction assay for optimization of marine molluscan cell cultures' * |
| DATABASE WPIL Week 8715, Derwent Publications Ltd., London, GB; AN 87-106345(15) * |
| DATABASE WPIL Week 9019, Derwent Publications Ltd., London, GB; AN 90-144892(19) * |
| DATABASE WPIL Week 9111, Derwent Publications Ltd., London, GB; AN 91-076866(11) * |
| LIFE SCIENCES COLLECTION. CAMBRIDGE SCIENTIFIC ABSTRACTS, BETHESDA, MD, US.; ABSTRACT NO. 82002579673 S. AUZOUX ET AL. 'In vitro culture of Perkinsus atlanticus (Apicomplexa, Perkinsea) parasite of Ruditapes decussatus dams (Mollusca, Bivalvia) from the south coast of Portugal' * |
| OCEANIC ABSTRACTS. CAMBRIDGE SCIENTIFIC ABSTRACTS, BETHESDA, MD, US.; ABSTRACT NO. 89-03320 SHIU-NAN CHEN 'Establishment, characterization and application of cell cultures from marine fish, crustaceans and molluscs' * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2735146A1 (en) * | 1995-06-12 | 1996-12-13 | Biopredic | Culturing marine invertebrate cells |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2684686B1 (en) | 1994-12-23 |
| FR2684686A1 (en) | 1993-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dadd | The nutritional requirements of locusts—V: Observations on essential fatty acids, chlorophyll, nutritional salt mixtures, and the protein or amino acid components of synthetic diets | |
| Bursell | The excretion of nitrogen in insects | |
| Widdows | Physiological ecology of mussel larvae | |
| Berthelin et al. | Storage metabolism in the Pacific oyster (Crassostrea gigas) in relation to summer mortalities and reproductive cycle (West Coast of France) | |
| Haberkorn et al. | Effects of Alexandrium minutum exposure on nutrition-related processes and reproductive output in oysters Crassostrea gigas | |
| Baumann et al. | Bacteriocyte-associated endosymbionts of insects | |
| Sasaki et al. | Growth and reproduction of the symbiotic and aposymbiotic pea aphids, Acyrthosiphon pisum maintained on artificial diets | |
| Lindroth et al. | Biochemical ecology of the forest tent caterpillar: responses to dietary protein and phenolic glycosides | |
| Bidochka et al. | Growth of the entomopathogenic fungus Beauveria bassiana on cuticular components from the migratory grasshopper, Melanoplus sanguinipes | |
| Bonte et al. | Developmental and reproductive fitness of Orius laevigatus (Hemiptera: Anthocoridae) reared on factitious and artificial diets | |
| Gatenby et al. | Growth and survival of juvenile rainbow mussels, Villosa iris (Lea, 1829)(Bivalvia: Unionidae), reared on algal diets and sediment | |
| Jehlík et al. | Effects of Chlorella sp. on biological characteristics of the honey bee Apis mellifera | |
| Douglas et al. | Nutrition and symbiosis. | |
| Ong’amo et al. | The role of wild host plants in the abundance of lepidopteran stem borers along altitudinal gradient in Kenya | |
| Rowe et al. | Lipid provisioning of turtle eggs and hatchlings: total lipid, phospholipid, triacylglycerol and triacylglycerol fatty acids | |
| Naz | The changes in the biochemical compositions and enzymatic activities of rotifer (Brachionus plicatilis, Müller) and Artemia during the enrichment and starvation periods | |
| Laabir et al. | Effect of diet on levels of amino acids during embryonic and naupliar development of the copepod Calanus helgolandicus | |
| Luévano-Martínez et al. | Mitochondrial alternative oxidase is determinant for growth and sporulation in the early diverging fungus Blastocladiella emersonii | |
| Böttger et al. | Suspension of annual gametogenesis in North American green sea urchins (Strongylocentrotus droebachiensis) experiencing invariant photoperiod—Applications for land-based aquaculture | |
| WO1993011224A1 (en) | Culture media for cells of marine invertebrates | |
| Brown et al. | Ontogenetic changes in amino acid and vitamins during early larval stages of striped trumpeter (Latris lineata) | |
| Shimizu et al. | Larval storage protein of the barnacle, Balanus amphitrite: biochemical and immunological similarities to vitellin | |
| Ivanović et al. | Metabolic response of cerambycid beetle (Morimus funereus) larvae to starvation and food quality | |
| Takagi et al. | Pronounced effects of the basal frond portion of the kelp Saccharina japonica on gonad qualities of the sea urchin Mesocentrotus nudus from a barren | |
| Slawinska et al. | Soybean somatic embryo maturation: composition, respiration and water relations1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP NO US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 122 | Ep: pct application non-entry in european phase |